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5.1 Introduction and prevalence
Tobacco use continues to be the single most significant avoidable cause 
of death globally and claims more than 8 million lives annually. Smoking 
is now highly prevalent throughout the developing world, with most 
 tobacco-related deaths occurring in low and middle-income countries, 
which are the targets of intensive tobacco industry interference and market-
ing (World Health Organization [WHO], 2019, Tobacco, para. 1). Smoking 
can be deadly for smokers as well as for nonsmokers. In addition to the 
direct effect of tobacco on users, second-hand tobacco smoke contributes to 
an additional 1.2 million deaths annually due to heart disease, cancer, and 
other diseases (WHO, 2019, Tobacco, para. 2). For most smokers, quitting 
smoking is the most important thing they can do to improve their health. 
Smoking cessation has been associated with significant health benefits, 
including reducing the risk of developing lung cancer, heart disease, and 
stroke. However, despite a high number of smokers wanting to quit, many 
find it challenging to do so. Few smokers are successful in quitting at their 
first attempt, and frequent relapses are common (Strong et al., 2011).
Not all smoking involves cigarettes. In the United States, an estimated 12.3 
million people aged 12 or older have been estimated to be cigarette smok-
ers, which translates to around 1 in 5 people aged 12 or older. An estimated 
8.8 million people aged 12 or older are current smokeless tobacco  users. 
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Concerning conventional cigarette smoking, these estimates suggested that 
3.4% of adolescents aged 12–17  years of age are monthly smokers, while 
an estimated 1.4% of adolescents report having used smokeless tobacco in 
the past month (U.S. Department of Health and Human Services, 2017). 
Although cigarette smoking in the United States has declined in the past two 
decades, this decline does not appear to reflect increased smoking cessation, 
but instead appears to be related to a substitution effect with an increasing 
number of young people reporting using electronic vaporizing devices such 
as electronic cigarettes (e-cigarettes) (U.S. Department of Health and Human 
Services, 2017). Gentzke et al. (2019) found a considerable increase in the use 
of e-cigarettes during the year 2017–18, with an increase of 77.8% among 
high school students and 48.5% among middle school students. By contrast, 
in countries such as China, about 45% of middle school children had heard 
of e-cigarettes, but only 1.2% reported using e-cigarettes in the past month 
(Xiao, Parascandola, Wang, & Jiang, 2018).
Meanwhile, in Korea, dual users of both conventional cigarettes and 
e-cigarettes were higher than e-cigarettes only users. Among middle and 
high school students, 5.1% of males and 1.2% of females use both conven-
tional cigarettes and e-cigarettes compared to 1.2% of males and 0.3% of 
females who use e-cigarettes on their own (Oh et al., 2019).
The research appears to show a lack of scientific evidence about the 
value of e-cigarettes as a smoking cessation tool. Instead, there is more ev-
idence of its potential to attract tobacco-naïve youth on nicotine as well 
as acting as a bridge to combustible tobacco use (Kalkhoran & Glantz, 
2016). Adkison et al. (2013) reported that although 85% of e-cigarette users 
claimed they were using the product to quit smoking at the initial wave, 
e-cigarette users were no more likely to have quit 1 year later than nonusers 
were. Another review found no significant effects on the efficacy and short 
term effects of e-cigarettes as a method for smoking cessation (Khoudigian 
et al., 2016) while e-cigarette use was significantly associated with a higher 
risk for subsequent cigarette smoking initiation and past 30-day cigarette 
smoking among 17,389 adolescents and young adults (Soneji et al., 2017).
5.2 Tobacco use disorder
According to the Diagnostic Statistical Manual Fifth Edition (DSM-5) of the 
American Psychiatric Association (2013), nicotine dependence is now referred 
to as tobacco use disorder. To be diagnosed with tobacco use disorder, a person 
must meet a minimum of 2 out of 11 criteria within 1 year. These include:
 (1) higher intake of tobacco or use over an extended period of time than 
intended;
 (2) persistent desire or unsuccessful attempts to cut down or control the 
use of tobacco;
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 (3) spending a lot of time to obtain or use tobacco;
 (4) strong craving or desire or urge to use tobacco;
 (5) recurrent use of tobacco resulting in failure in fulfilling 
responsibilities at work, school, or home;
 (6) continued use of tobacco despite having persistent or recurrent 
social or interpersonal problems caused or exacerbated by the effects 
of tobacco (e.g., having conflicts with others about tobacco use);
 (7) giving up or reducing important social, occupational, or recreational 
activities due to tobacco use;
 (8) recurrent tobacco use in situations that are physically hazardous;
 (9) continued tobacco use despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have 
been caused or exacerbated by tobacco;
 (10) tolerance;
 (11) withdrawal.
5.3 Screening and clinical assessment methods
Assessing the factors to help smokers quit may help clinicians to 
formulate an initial treatment plan. It informs clinicians on how to as-
sess smokers’ characteristics and how to use the assessment’s results 
to inform treatment. Clinicians need to note that each smoker will 
have different concerns, motivation, and experience regarding quit-
ting smoking, as well as different ability to sustain abstinence, which 
means that the same treatments will not work with every smoker. By 
using triage assessments, clinicians will be able to identify unique bio-
psychosocial, spiritual, and cultural factors that contribute toward the 
smoker’s motivation, initial cessation, and relapse prevention, and use 
the knowledge of these individual differences to tailor a treatment that 
best meets the needs of the individual (Niaura & Shadel, 2003). Triage 
assessments are brief screening tools that allow for informed decisions 
about the best course of treatment for smokers. Five measures of clinical 
areas during smoker triage are motivation, nicotine dependence, past 
quit attempts and smoking history, substance abuse comorbidity, and 
psychiatric comorbidity.
5.3.1 Measuring motivation to quit
The Readiness to Quit Ladder has shown to be an excellent objec-
tive measure in measuring readiness to quit smoking and with actual 
quit attempts. It has 10 response options that assess motivation along 
the continuum, from not considering quitting smoking at all shortly 
to having already quit smoking. Another popular tool to measure 
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one’s  readiness to change is the University of Rhode Island Change 
Assessment (URICA) (McConnaughty, Prochaska, & Velicer, 1983). It 
has four scales, precontemplation, contemplation, action, and mainte-
nance to change.
5.3.2 Measuring tobacco dependence
Two questions from the Heaviness of Smoking Index (HSI) are used as 
an assessment of smokers’ current nicotine dependency level (Heatherton, 
Kozlowski, Frecker, Rickert, & Robinson, 1989). One item assesses time to 
the first-morning cigarette, and the other asks for the individual’s daily 
smoking rate. Another widely used questionnaire to assess tobacco depen-
dence level is the Fagerstrom Test for Nicotine Dependence (Heatherton, 
Kozlowski, Frecker, & Fagerstrom, 1991). This questionnaire has six items 
with a possible score range of 1–10.
5.3.3 Past quit attempts and smoking history
The length of the most extended past quit attempt, and the length of 
the most recent quit attempt are the strongest determinants of a smoker’s 
success in quitting smoking. Four simple questions can be asked (Niaura 
& Shadel, 2003):
 (a) How many times in the past have you made a serious attempt to quit 
smoking?
 (b) What was the longest period of time that you were able to quit 
smoking?
 (c) When was your most recent serious attempt to quit smoking?
 (d) How long were you able to stay quit during your most recent quit 
attempt?
5.3.4 Other substance use and comorbid psychiatric disorder
Drug and alcohol use, misuse, and abuse have been associated with 
the difficulty of giving up smoking. It is thus essential to ask about past 
use and treatment, and present use of alcohol, overuse of prescription 
medications, and/or illegal drugs. Some studies have reported a signif-
icant relationship between depression and smoking. For example, in one 
study of adolescents in the United States aged 12–17 in 2016, 0.9% of those 
with a past year major depression episode were daily cigarette smokers 
in the past month compared with 0.4% of those without a past year ma-
jor depression episode (U.S. Department of Health and Human Services, 
2017). Accordingly, it has been suggested that treatment protocols should 
include a brief assessment for assessing mood disorder, which involves 
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asking about the current or past history of treatment for mood disorders 
and psychiatric treatment. Niaura and Shadel (2003) outlined an example 
of this type of measure and suggested the following simple questions with 
yes or no answer choices:
 (a) Have you ever received treatment for a mental health problem?
 (b) Has there been a time in your life when you were down or depressed 
most of the day, nearly every day for a period of 2 weeks?
The Brief Screener for Tobacco, Alcohol, and Other Drugs (BSTAD), 
developed by the National Institute on Alcohol Abuse and Alcoholism, 
is a brief screening test to triage pediatric patients rapidly. It is a valid, 
reliable, and promising screening tool for identifying problematic tobacco, 
alcohol, and marijuana use in pediatric settings in the past year. Designed 
for use with 12–14-year-old adolescents, this tool starts by asking ques-
tions about friends’ use, followed by personal use questions. The order is 
reversed for adolescents ages 15–17 (and 14-year olds who were in high 
school). Participants who answer yes to personal use in any domain (to-
bacco, alcohol, and drugs) are asked additional questions to gauge the 
frequency of use during the past 30, 90, and 365 days. The BSTAD could be 
administered via interviewer-administration or self-administration using 
an iPad, the latter of which was well received by participants. The BSTAD 
serves as a quick and straightforward method to triage patients into low-
risk and high-risk groups. Additionally, it is very efficient to be used in a 
busy clinic and yields more accurate and reliable responses from adoles-
cents compared with administration by an interviewer for sensitive issues 
(Kelly et al., 2014).
5.4 Epidemiology
The National Youth Tobacco Survey in the United States documents 
a rapid increase in the use of e-cigarettes in young people—3.8 million 
in 2018, which constituted an increase of 1.5 million compared to 2017. 
Several factors are identified to explain why these new activities are 
popular or adopted (Tsai et  al., 2018). These include the presence of 
a family member who is an e-cigarette user, the availability of multi-
ple flavors, which increased the attraction for its use, or the belief that 
e-cigarettes are harmless. Another factor is technical innovation. For 
example, the invention of a new e-cigarette device called JUUL with 
nicotine content as high as a pack of 20 cigarettes has raised concerns. 
In a short time, it has become the most popular device in the e-cigarette 
market, and this has been driven by the small, USB-shape appearance 
that makes it unidentifiable and easy for young people to use discreetly. 
According to Willett et al. (2019), 25% of 1012 respondents in an online 
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survey of 15–24-year olds identified photos of the JUUL device that con-
tained a nicotine compound.
Tobacco use appears to peak in early and middle adolescence among 
middle and high school students (Marshall et al., 2006; Villanti, Boulay, & 
Juon, 2011). Such elevated rates of tobacco (nicotine) use in adolescence 
have long-lasting consequences and can affect young people’s health 
and well-being as well as their longer-term functioning as adults (Ryzin, 
Fosco, & Dishion, 2012). Tobacco (nicotine) use during adolescence (i.e., 
under 17 years) is a strong predictor of future dependence and addiction 
(Brook, Brook, Zhang, Cohen, & Whiteman, 2002).
According to the World Health Organization (2013), within the South-
East Asian region, the prevalence of current smoking in young male adoles-
cents (13–15-year olds) was higher in Malaysia (35%) and Indonesia (41%) 
than that of the neighboring countries (i.e., Philippines 28%, Thailand 24%, 
and Myanmar 23%). In Malaysia, 5 million adolescents below 18 years are 
estimated to smoke tobacco (nicotine). In 2015, research indicated that 1 
in 10 adolescents in Malaysia were at risk of becoming smokers, while 
33.2% of schoolboys were current smokers (Hum, Hsien, & Nantha, 2016). 
Dahlui et al. (2015) further stated that smoking is common among men, 
but the prevalence is increasing, especially among young women; 4% of 
the girls smoked; compared to 13% of boys and almost a third of current 
smokers were girls. However, the result might be due to underreporting 
of smoking among girls.
Further exploration based on qualitative approaches showed that 
the perspective on the effectiveness and safety of vaping among va-
pers showed, at least anecdotally, that vaping was used to assist in 
quitting smoking (Rahman, Nik Mohamed, & Jamshed, 2015). The 
findings showed that vaping was used as a quit smoking aid, which 
reduced tobacco consumption as a cheaper and healthier alternative 
device to nicotine to manage withdrawal symptoms (Nik Mohamed, 
2015). However, further study is needed to determine the effects, as 
many vapers, especially adolescents, develop dual smoking behavior 
as a consequence of vaping.
5.5 Comorbidity
Tobacco use and dependence are comorbid frequently with other 
substance use disorders (SUD) as well as with emotional and behav-
ioral problems. For example, nicotine dependence has been reported 
to cooccur in the use of transdermal nicotine patches. In a study by 
Lewinsohn, Rohde, and Brown (1999), daily smoking in adolescence 
could increase the likelihood of future cannabis, hard drug, and 
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 multiple drug use  disorders. In total, 27% of the adolescents who 
smoked daily developed cannabis use disorders compared to 8% of 
those who had never smoked by adolescence. Quitting smoking did 
not reduce the risk of future SUD. These findings highlight the sub-
stantial degree of comorbidity across various types of substance abuse 
and dependence.
Tobacco (nicotine) use is associated with a variety of maladaptive 
consequences and elevated mental health problems (Liao, Huang, Huh, 
Pentz, & Chou, 2013; Swahn et al., 2012). These include a likelihood of de-
pression and anxiety (Fluharty, Taylor, Grabski, & Munafò, 2017; Johnston, 
Bachman, & Schulenberg, 2012; Liao et al., 2013) and other at-risk problem 
behaviors such as violent crime (Brook et al., 2002; Lennings, Copeland, & 
Howard, 2003), early teenage sexual activity, academic failure, and antiso-
cial or delinquent activity (Dishion & Patterson, 2006; Ryzin et al., 2012). 
Other issues that relate to nicotine addiction are the abuse of or depen-
dence on other substances, such as alcohol and marijuana use, especially 
in young adulthood (Liao et  al., 2013; Palmer et  al., 2009) if an experi-
mentation with tobacco use starts much earlier in adolescence (Johnston 
et al., 2012). Further, nicotine dependence also predicts later respiratory 
problems and may serve as an independent lifetime risk factor for lung 
cancer (Liao et al., 2013).
5.6 Course and outcome
Trajectories of the use of tobacco (nicotine) in adolescence do not oc-
cur in a vacuum. However, they are necessarily related to the significant 
developmental transitions that may influence the onset of tobacco (nico-
tine) use, such as pubertal timing, school transitions, and other significant 
life events. It is also noticeable that patterns of substance use like tobacco 
(nicotine) change rapidly during early adolescence and late adolescence, 
with e-cigarette use the most current trend among adolescents. Early ex-
perimentation with substance use often begins during the early years 
of adolescence, typically in the context of negative peer influence, with 
readily available substances such as cigarettes (including e-cigarette), al-
cohol, and inhalants (Griffin, 2010). The prevalence of tobacco (nicotine) 
use often intensifies throughout adolescence. Some adolescents will have 
already started their experimentation with new substances such as mar-
ijuana, hallucinogens, cocaine, and the nonmedical use of prescription 
drugs. Tobacco (nicotine) use usually reaches its peak during late adoles-
cence and early adulthood, and for most young people, it begins to decline 
in the mid to late 20s, with a more rapid decline occurring in adulthood 
(Griffin, 2010).
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5.7 Risk and protective factors
There are various theories that have been used to explain the risk and 
protective factors of tobacco use among adolescents. Social influence 
models appear to be useful and encourage systems thinking that involves 
the consideration of social influence theories, including Bandura’s Social 
Learning Theory (Clayton, Leukfeld, Donohew, Bardo, & Harrington, 1995; 
Corrigan, Loneck, Videka, & Brown, 2007). For instance, studies by Duncan, 
Duncan, Biglan, and Ary (1998) were based on Patterson’s Social Context 
Model; Atkinson, Richard, and Carlson (2001) tested Oetting’s Primary 
Socialization Theory; and Kelder and Perry (1993) utilized Perry and Jessor’s 
Social Influence Model. Other researchers prefer to use a biopsychosocial 
framework to describe adolescent’s thinking, with an emphasis on systems 
thinking, as well as an individual’s interaction with their family, peers, and 
community (Corrigan et al., 2007). Another approach, termed social devel-
opment theory, uses a developmental perspective, a systems approach, and 
social influence theories to elucidate a framework of risk and protective 
factors. According to this theory, different social influences have varying 
importance at different points in a child’s life. As children progress through 
stages, subsequent success is predicated on their past success. When the 
children’s socialization experience is consistent and stable, there is a greater 
likelihood of bonding with adults, which leads to attachment, commitment, 
and investment in the beliefs and values of the children (Hawkins, 1996).
For decades, researchers have recognized that many possible causal 
factors contribute to tobacco (nicotine) abuse among adolescents. These 
variables are known as risk factors. Coie et al. (1993, p. 1013) defined risk 
factors as “variables associated with a high probability of onset, greater 
severity, and longer duration of major mental health problems.” However, 
Corrigan et al. (2007) stressed that not all adolescents who are exposed 
to risk factors develop tobacco (nicotine) problems and dependency, but 
there seem to be other variables that keep adolescents from experimenting 
with tobacco (nicotine) use and misuse. These variables are known as pro-
tective factors and are defined by Coie et al. (1993, p. 1013) as “conditions 
that improve people’s resistance to risk factors and disorder.”
Protective factors are those that facilitate healthy development 
(Corrigan et al., 2007; Glantz & Pickens, 1992; Jessor, 2014). By contrast, 
risk factors are conceptualized as those factors that inhibit an adolescent’s 
natural development. For instance, Tarter and Vanyukov (1997) argue that 
substance abuse arises from suboptimal age-appropriate cognitive, emo-
tional, and behavioral skills. As a result, substance use such as tobacco 
(nicotine) results from more distressful development progress among ad-
olescents caused by specific risk factors. However, further research to de-
termine the salient risk and protective factors in different developmental 
stages and times in adolescence are much needed (Corrigan et al., 2007).
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Arthur, Hawkins, Pollard, Catalano, and Baglioni (2002) have further 
explained a framework of risk and protective factors of adolescents with 
substance abuse that can be used as guidelines for tobacco (nicotine) and 
e-cigarette use, with cautions that not all risk and protective factors are 
present for tobacco (nicotine) abuse in adolescence. Both risk and pro-
tective factors explicated by Arthur et al. (2002) can be described in four 
different categories: individual/peer, family, school, and community. 
Individual/peer risk factors include rebelliousness, attitudes favorable to 
drug use, peer drug use, peer rewards for antisocial behavior, impulsive-
ness, early initiation of antisocial behavior, attitudes favorable to antisocial 
behavior, peer antisocial behavior, sensation seeking, and peer rejection. 
Family risk factors include poor family management, family history of 
antisocial behavior, parental attitudes favorable to antisocial behavior, 
high family conflict, and parental attitudes favorable drug use. School 
risk factors include academic failure and low commitment to the school, 
while community risk factors include low neighborhood attachment, high 
transition and mobility, perceived availability of drugs, community disor-
ganization, laws and norms favorable to drug use, and extreme economic 
deprivation.
Furthermore, Arthur et al. (2002) explained four different categories 
of influences that act as protective factors in adolescents’ substance 
abuse behavior such as, firstly, individual/peer protective factors. The 
individual/peer protective factors include belief in the moral order, 
prosocial peer attachment, social skills, resilient temperament, and so-
ciability. The second category is family protective factors. The family 
protective factor includes opportunities for prosocial family involve-
ment, rewards for prosocial family involvement, and family attachment. 
Thirdly, there is the school protective factor. The school protective factor 
includes opportunities for prosocial school involvement and rewards 
for prosocial school involvement. The fourth category is community 
protective factors. The community protective factor includes opportu-
nities for prosocial community involvement and rewards for prosocial 
community involvement.
According to the Search Institute (2019), family factors (e.g., parental 
nonsmoking, family monitoring, and family bond) are usually associated 
with a lower risk of daily tobacco (nicotine) use among urban adolescents. 
By contrast, low school connectedness, academic difficulties, and unde-
sirable neighborhood environment factors would increase the likelihood 
of smoking among diverse groups of adolescents. However, the roles of 
community factors, religiosity, and spirituality in tobacco use remain less 
known.
During middle adolescence, young people spend less time with parents, 
so that their level of involvement with the family decreases along with the 
frequency and quality of adolescent-parent communication (Hill, Graham, 
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Caulfield, Ross, & Shelton, 2007; Loeber et al., 2000). Consequentially, early 
adolescents are particularly vulnerable to negative peer influence related 
to substance use, including tobacco (nicotine) use (Kelly et al., 2014; Ryzin 
et  al., 2012). However, the influence of negative peer influence on ado-
lescents’ tobacco (nicotine) use has produced inconsistent findings across 
different racial/ethnic groups. Continuous exposure and susceptibility to 
tobacco advertising can also affect smoking initiation among adolescents 
(Hanewinkel, Isensee, Sargent, & Morgenstern, 2011; Liao et al., 2013).
Tobacco (nicotine) use often starts among a small percentage of adoles-
cents during their early adolescence. The percentage increases as they hit 
puberty and throughout adolescence (Ryzin et al., 2012). Age also seems 
to be an essential factor related to tobacco (nicotine) use, in that older than 
younger adolescents smoke (Malcon, Menezes, & Chatkin, 2003; Teodoro, 
Cerqueira-Santos, Araujo de Morais, & Koller, 2007). Furthermore, smok-
ing in late adolescence can be a powerful predictor of smoking in adult-
hood (Fagan, Brook, Rubenstone, & Zhang, 2005). It is essential to point 
out that younger adolescents who engage in early tobacco experimenta-
tion may befriend peer groups whose members are smokers, and this in-
creases their chances of becoming a future smoker.
The fundamental assumption is that adolescent behaviors result from 
individual attributes, including biological and genetic factors, within the 
individual’s primary social contexts, ranging from the proximal contexts 
of family and peers, school, community, and the larger society. However, 
much of what is known regarding the risk and protective factors of ado-
lescent tobacco (nicotine) use comes from studies of predominately white 
adolescents. Thus, it is unclear whether the findings can be generalized to 
other populations around the world.
In summary, the risk and protective factors can be classified into four 
different categories: individual/peer, family, school, and community. All 
four factors must be assessed when determining which risk and protective 
factors are affecting a child’s life before deciding upon a specific interven-
tion program. It is also insufficient merely to identify child risk behaviors 
because every practitioner, researcher, and policymaker must identify and 
determine the specific threats that a child encounters, or the specific lack 
in their protection. Thus, identifying the risk and protective factors is the 
beginning of intervention that could take place at individual/peer, family, 
school, and/or community contexts.
5.8 Evidenced-based clinical strategies for prevention and 
treatment of nicotine addiction and e-cigarettes use
Tobacco smoking in adolescents is a problem that should be prevented 
at primary, secondary, and tertiary levels and treated due to its negative 
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consequences. The chronicity of tobacco smoking imposes a toll on a per-
son’s overall health. Available data showed that 90% of the people who 
die due to smoke-related health conditions have a long history of using to-
bacco since their adolescent years (CDC, 2015). Smoking also increases the 
risk for subsequent drug use in later life (Levine et al., 2011; McQuown, 
Belluzzi, & Leslie, 2007) and has an impact on adolescents’ memory, atten-
tion, and learning (Office of the Surgeon General, 2014).
The addictive potential of nicotine is dependent on its fast activation 
in the bloodstream. Research has shown a varying rate of nicotine deliv-
ery across e-cigarette variants. Those who are classified as experienced 
users showed a more significant increase in blood nicotine as compared 
to nonexperienced users (Farsalinose et  al., 2015; Hajek et  al., 2014). 
The peak nicotine level of experienced users was observed within just 
2–5 minutes, which is indicative of the e-cigarettes’ addictive potential 
(St. Helen, Havel, Dempsey, Jacob III, & Benowitz, 2016). The process of 
becoming addicted to tobacco or e-cigarette use involves several stages. 
The US Department of Health and Human Services (1994) highlighted 
five stages: (a) the preparatory stage (when the knowledge and expecta-
tions about tobacco smoking are formed); (b) the trying stage (when the 
cigarettes are first tried); (c) the experimentation stage (characterized by 
irregular use of substance occurring in specific situations); (d) regular 
use (when smoking becomes regular with a specific pattern, for example, 
smoking after each meal); and finally (e) the addiction phase. In short, the 
process of addiction does not occur within a short time frame but instead 
develops over time.
5.8.1 Smoking policy in children and adolescents
US Department of Health and Human Services, Centers for Disease 
Control and Prevention (2012) emphasized the importance of having 
government legislation place to assist in the prevention of tobacco smok-
ing in adolescents. Some relevant legislation or guidelines include: the 
CDC Best Practices for Comprehensive Tobacco Control Programs 2014 
(outlines programs for implementing interventions); the World Health 
Organization (WHO) Framework Convention on Tobacco Control 
(worked on trade liberalization, foreign investment, and trading of to-
bacco products); the World Health Organization MPOWER (reduce to-
bacco demand at country level by implementing components such as 
monitoring of tobacco use and offering help to those who wants to quit); 
the Truth Initiative (study and provide public about the impact of tobacco 
use); and the Campaign for Tobacco-Free Kids (advocating public poli-
cies in the prevention of smoking in children). Other bodies that also play 
important roles are the American Lung Association and the American 
Academy of Pediatrics (AAP).
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5.8.2 Effective tobacco prevention strategies for adolescents
Smoking prevention measures for adolescents can be under-
taken in the primary care setting, family-based, school-based, and 
 community-based, and in the form of government legislation and 
initiatives. In the primary care setting, education and counseling are 
one of the most essential and universal interventions being practiced 
by healthcare providers. Counseling can be provided individually or 
in groups, and can be undertaken on the phone. The effectiveness of 
this type of intervention has been confirmed in several research studies 
(Moyer, 2013; Patnode et  al., 2013). Familial smoking behavior or the 
acceptance of smoking in a family is also a risk factor for the initia-
tion of smoking in adolescents. It is, therefore, necessary for the focus 
of intervention also to be targeted toward family members. Thomas, 
Baker, Thomas, and Lorenzetti (2015) revealed that family‐based inter-
ventions for smoking prevention could deter children and adolescents 
from starting to smoke, and promote nonsmoking behavior in young 
people. Furthermore, adding the family‐based component to a school 
intervention may also increase its effectiveness.
In addition, Carson et al. (2011) stated that community-based inter-
vention could also be effective in curbing smoking behavior among ad-
olescents. However, further study should be carried out intensively as 
the findings were inconsistent, with some methodological flaws. On the 
contrary, a school-based smoking prevention program has several ad-
vantages. First, it can be provided to all children attending the school, 
so that no one misses out on the program. Second, school-based inter-
ventions do not entail the same costs as specialized counseling centers. 
In line with this view, the Centers for Disease Control and Prevention 
(1994) has outlined several guidelines and recommendations on an effec-
tive school-based tobacco prevention programs. The guidelines include 
the following:
1. Development and enforcement of tobacco use policy in schools.
2. Education on negative consequences of tobacco use, social influence, 
the role of peers, and skills for refusal.
3. Education on tobacco use prevention from kindergarten through 12th 
grade.
4. Training for teachers.
5. Parental and family involvement in supporting the prevention 
programs.
6. Supporting students and school staff in tobacco cessation.
7. Assessment of the prevention program regularly.
The findings underlined the importance of having intervention pro-
grams that are specifically tailored to the appropriate developmental 
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stages, for instance, enhancing personal competencies in elementary 
school students and social norms in early adolescents.
5.8.3 Nonpharmacological interventions for nicotine addiction 
in adolescents
Nonpharmacological management has been widely used in the pre-
vention and intervention of smoking cessation in adolescents. Among the 
most widely used interventions are cognitive behavior therapy (CBT), 
contingency management (CM), and motivational enhancement therapy 
(MET), which was based on the motivational interviewing (MI) approach 
and practices.
5.8.3.1 Cognitive behavior therapy
CBT is a structured therapeutic approach that is effective for adoles-
cents’ smoking cessation. The aim of CBT in smoking cessation is to iden-
tify and change the cognitive processes that maintain tobacco use, followed 
by teaching the necessary skills or strategies to stop smoking and maintain 
the cessation of abstinence. CBT uses the ABC Model, which refers to how 
the (A) antecedents (external events) cause the formation of (B) belief (irra-
tional beliefs), which produces (C) consequences (emotions and behaviors) 
in a person. In short, a person’s emotions and behaviors are not directly 
linked to a specific life event, but more to how the events are evaluated 
and processed cognitively (Beck, 2011; Oltean, Hyland, Vallières, & David, 
2017; Sarracino et al., 2017). The CBT model looks at substance use as a 
coping strategy, with the presence of specific triggers activating a person’s 
core belief, which leads to individual unhealthy responses (e.g., using 
substances). Milton et al. (2004) described some essential elements in CBT 
targeting smoking cessation as follows: (a) establish one’s self-awareness 
regarding tobacco use, (b) increase motivation to quit, (c) preparation for 
quitting, (d) providing strategies to maintain abstinence.
5.8.3.2 Contingency management
Contingency management is a form of behavioral therapy where pos-
itive behavioral changes are rewarded to reinforce the behavior. In the 
context of substance used treatment, the positive change can be negative 
urine drug results. The reward can be monetary-based or in the form of 
vouchers that can be exchanged for goods. Contingency management is 
not explicitly limited to managing substance use, but is used also in the 
context of other psychiatric treatments (Petry, 2011), for example, it can 
involve promoting regular follow-ups in treatment settings or increasing 
adherence to medications. For contingency management to be effective, 
there is a need to increase the reenrolments (e.g., an increase in voucher 
amounts) with sustained positive behavior (Petry et al., 2005).
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5.8.3.3 Motivational-based interventions
Motivational-based interventions often use the transtheoretical model 
(TTM) of change, which was developed and introduced by Prochaska and 
DiClemente (1983). The TTM model uses the stages of change model that 
consists of five stages: precontemplation, contemplation, preparation, ac-
tion, and maintenance. Interview techniques in MI cover four main fea-
tures, namely, open-ended questions, affirmations, reflective listening, 
and summarizing. The practice of MI should be based on five general prin-
ciples: (a) express empathy through reflective listening, (b) identify a dis-
crepancy between the client’s goals or values and their current behavior, 
(c) avoid argument or confrontation, (d) adjust to client resistance rather 
than opposing, and (e) support self-efficacy and optimism. Moreover, mo-
tivational enhancement therapy (MET) is a form of counseling approach 
based on MI principles that are designed to produce internally motivated 
change (NIDA, 2018).
5.8.4 Other forms of intervention
5.8.4.1 Web-based smoking cessation intervention
The Internet has become the most crucial tool of communication in 
today’s world and is particularly relevant for adolescent interventions. 
However, results show that the effectiveness of using web-based inter-
ventions for smoking cessation in college students and adolescents is un-
convincing (Hutton et  al., 2011). Interactive and tailored internet‐based 
interventions, with or without additional behavioral support, were found 
to be moderately more effective than nonactive controls at 6 months or 
more, but with no evidence of superiority against other interventions 
(Taylor et al., 2017).
5.8.4.2 Text messaging
Interventions using mobile phones had several advantages, including 
the low cost of implementation and the lack of need to come to treatment 
centers, which resolved the issue of stigma. Furthermore, mobile phone 
and text messaging have proven to be the preferred way to communicate 
with adolescents. A study by Scott-Sheldon et al. (2016) has explored the 
effectiveness of text messaging in smoking cessation. Findings showed 
that smokers who received a text-messaging intervention were more 
likely to abstain from smoking (continuous abstinence) and able to reduce 
their cigarette consumption.
A further study by Haug, Schaub, Venzin, Meyer, and John (2013) also 
supported the previous study that text-messaging intervention of smok-
ing cessation showed a higher decrease in cigarette consumption among 
adolescents.
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5.8.4.3 Pharmacological interventions for nicotine addiction in 
adolescents
Currently, there is no FDA approved medication to assist smoking 
cessation in children or adolescents. Various sets of guidelines address 
smoking issues in adolescents with recommendations regarding smoking 
management, such as the American Cancer Society, American Academy 
of Pediatrics (AAP) Committee on Substance Abuse, the United States 
Department of Health and Human Services (DHHS), the Department of 
Veterans Affairs (VA)/Department of Defense (DoD), the National Institute 
for Health and Clinical Excellence (NICE), and the Institute for Clinical 
Systems Improvement (ICSI). All the guidelines mentioned above give em-
phasis and recommendations on providing education, preventive measures, 
screening, and behavioral interventions among adolescents. However, their 
recommendations toward the use of medications differ. AAP, VA/DOD, 
and ICSI do consider the possibility of using medications. As for the NICE 
guidelines, their recommendation for medication is limited to the use of nic-
otine replacement therapy (NRT), but not Bupropion or Varenicline for ad-
olescents less than 18 years old. The 2008 DHHS also does not recommend 
the use of medications in adolescents less than 18 years old.
5.8.4.4 Nicotine replacement therapy
NRTs aim to replace the nicotine obtained from cigarettes to enable one 
to reduce and subsequently stop smoking. NRT, which can be found in 
the form of lozenges, gums, spray, inhaler, patches, or sublingual tablets, 
is well accepted, has been well researched indicating its effectiveness for 
the treatment of nicotine dependence in adults (Theng, Wahab, Wahab, 
Sidi, & Das, 2019), and is often used with other behavioral interventions in 
the management of smoking cessation. The current availability of various 
forms of NRT also enables the patient to tailor the therapy based on their 
previous daily nicotine use. However, to date, only a handful of studies 
have examined the effectiveness of NRTs in adolescents.
5.9 Concise summary of key clinical points
The negative consequences of cigarette use have long been discussed. 
Smoking initiation during adolescence increases the likelihood of not only 
being tobacco-dependent but also developing a dependence on other 
substances in adulthood. The immaturity of the brain allows nicotine to 
disrupt brain function to a greater extent than in adults. Several factors 
have been identified as increasing the risk of adolescents to be nicotine de-
pendent. These factors include starting to smoke at an early age, parental 
smoking behavior, negative peer pressure, a lack of knowledge  regarding 
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smoking, and a negative school environment. However, factors such as 
high self-control and regulation, presence of parental role modeling of 
positive behavior, positive parent-child communication, high school com-
mitment, and community engagement can act as protective factors and 
reduce the risk of becoming addicted to or dependent on nicotine.
Approaches to treatment should involve a comprehensive assessment 
to assist in the formulation of the personal treatment plan by taking into 
consideration the biopsychosocial-spiritual-cultural factors that may con-
tribute toward the person’s tobacco cessation and relapse prevention. 
Assessment should take note of past quit attempts, substance use comor-
bidity, and psychiatric comorbidity, which may also determine a person’s 
chance of achieving recovery from nicotine addiction.
In general, the treatment of nicotine addiction in adolescents is similar 
to the methods used with adults. However, the use of pharmacological 
treatment in adolescents is still controversial. To date, there is no FDA ap-
proved medication to assist smoking cessation in children or adolescents. 
Further research is needed to evaluate the use of these medications in the 
young population to see the risks and benefits. In terms of nonpharma-
cological treatment, behavioral interventions have been widely studied. 
Among the highly recommended behavioral interventions are cogni-
tive behavioral strategies, motivational strategies, and social influence 
strategies.
As the effectiveness of treatment is still generally debatable, a more 
careful approach should be targeted to prevent the first use of cigarettes 
in adolescents. Smoking prevention measures for adolescents can be ini-
tiated in the primary care setting, within the family, in school, in the com-
munity, and by the government.
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